A Study to Evaluate Glucose and Insulin Response to Nutralin
The purpose of this study is to evaluate how an investigational food product affects a healthy person's blood sugar and insulin levels.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||A Study to Evaluate Glucose and Insulin Response to Nutralin|
- Glucose blood level [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]Measure the change in blood sugar levels
- Dosage of Insulin [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]Measure the levels of insulin
Biospecimen Retention: Samples Without DNA
|Study Start Date:||June 2010|
|Study Completion Date:||September 2010|
|Primary Completion Date:||August 2010 (Final data collection date for primary outcome measure)|
All 10 subjects in the study will consume the investigational food product.
Dietary Supplement: Nutralin
Food product to be taken 15 minutes prior to each of the three main meals of the day.
Other Name: No other names at this time.
The investigational food product has helped decrease the amount of insulin needed in treating diabetic dogs and has improved the dogs' longevity and quality of life. Observational analysis by trained veterinarians has indicated that the natural fluctuations in blood glucose levels do not exist in dogs using the product. The hypothesis for this study is that healthy human subjects will have an increase in insulin levels after consuming the investigational food product.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01275820
|United States, South Dakota|
|Avera Research Institute|
|Sioux Falls, South Dakota, United States, 57105|
|Principal Investigator:||Edward Zawada, MD||Avera McKennan Hospital & University Health Center|